drug protocol number

1305-0023

drug sponsor

Boehringer Ingelheim Middle East & North Africa

drug study

BI 1015550

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh) , King Abdulaziz Medical City NG (Riyadh) , King Abdulaziz University Hospital (Jeddah),King Fahad Specialist Hospital (Dammam)

drug status

Ongoing

drug phase